Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy
- PMID: 17278216
- PMCID: PMC4065972
- DOI: 10.3748/wjg.v13.i4.524
Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy
Abstract
Aim: To assess the usefulness of two independent histopathological classifications of rectal cancer regression following neo-adjuvant therapy.
Methods: Forty patients at the initial stage cT3NxM0 submitted to preoperative radiotherapy (42 Gy during 18 d) and then to radical surgical treatment. The relationship between "T-downstaging" versus regressive changes expressed by tumor regression grade (TRG 1-5) and Nasierowska-Guttmejer classification (NG 1-3) was studied as well as the relationship between TRG and NG versus local tumor stage ypT and lymph nodes status, ypN.
Results: Complete regression (ypT0, TRG 1) was found in one patient. "T-downstaging" was observed in 11 (27.5%) patients. There was a weak statistical significance of the relationship between "T-downstaging" and TRG staging and NG stage. Patients with ypT1 were diagnosed as TRG 2-3 while those with ypT3 as TRG5. No lymph node metastases were found in patients with TRG 1-2. None of the patients without lymph node metastases were diagnosed as TRG 5. Patients in the ypT1 stage were NG 1-2. No lymph node metastases were found in NG 1. There was a significant correlation between TRG and NG.
Conclusion: Histopathological classifications may be useful in the monitoring of the effects of hyperfractionated preoperative radiotherapy in patients with rectal cancer at the stage of cT3NxM0. There is no unequivocal relationship between "T-downstaging" and TRG and NG. There is some concordance in the assessment of lymph node status with ypT, TRG and NG. TRG and NG are of limited value for the risk assessment of the lymph node involvement.
Figures
References
-
- National Comprehensive Cancer Network. Rectal Cancer. Clinical Practice Guidelines in Oncology. Version 2.2006; cited 2006-04-24. Available from: http://www.nccn.org/professionals/physician_gls/PDF/rectal.pdf.
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
-
- Church JM, Gibbs P, Chao MW, Tjandra JJ. Optimizing the outcome for patients with rectal cancer. Dis Colon Rectum. 2003;46:389–402. - PubMed
-
- Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, Orsay C, Church J, Otchy D, Cohen J, et al. Practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 2005;48:411–423. - PubMed
-
- Nasierowska-Guttmejer A. Histopathological and immunohistochemical markers in rectal cancer after preoperative radiochemotherapy. J Oncol. 2001;51 Suppl 3:1–57 (in Polish, with English abstract).
MeSH terms
LinkOut - more resources
Full Text Sources
